Status:
COMPLETED
Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
Lead Sponsor:
AAADRS Clinical Research Center
Collaborating Sponsors:
UCB Pharma
Conditions:
Perennial Allergic Rhinitis
Eligibility:
All Genders
12-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.
Eligibility Criteria
Inclusion
- ICF signed
- Diagnosis of PAR for 6-12 months greater
- 12 years and older
- Decreased nasal NO values at baseline
- Compliance and ability to perform maneuvers and responsibilities
Exclusion
- Oral or systemic steroids for 60 days prior
- Inhaled, nasal, nebulized steroids w/i 4 weeks
- Hospitalization or life threatening asthma
- Use of nasal or oral antihistamines w/i 4 weeks
- Upper or lower airways infection
- Direct cigarette smoke exposure
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00894231
Start Date
January 1 2009
End Date
August 1 2009
Last Update
September 4 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AAADRS
Coral Gables, Florida, United States, 33134